The histopathological evaluation of drug-induced liver injury

Management of toxicities of immune checkpoint inhibitors

(2016) Lavinia Spain et al.   CANCER TREATMENT REVIEWS

Amoxicillin–Clavulanate-Induced Liver Injury

(2016) Andrew S. deLemos et al.   DIGESTIVE DISEASES AND SCIENCES

Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury

(2015) Robert J Fontana et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Identification and Characterization of Cefazolin-Induced Liver Injury

(2015) Saleh A. Alqahtani et al.   Clinical Gastroenterology and Hepatology

Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports

(2015) Einar S. Björnsson et al.   HEPATOLOGY

Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

(2015) Ryoko Suzuki et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network

(2014) Mark W. Russo et al.   HEPATOLOGY

Autoimmune hepatitis-like reaction developing in a patient treated with interferon-β1a

(2014) Amrita Mishra et al.   HISTOPATHOLOGY

Histological features and severity of oxaliplatin-induced liver injury and clinical associations

(2014) ILKe Nalbantoglu et al.   Journal of Digestive Diseases

A review of methotrexate-associated hepatotoxicity

(2014) Roopjeet K. Bath et al.   Journal of Digestive Diseases

Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases

(2013) Marwan Ghabril et al.   Clinical Gastroenterology and Hepatology

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

(2013) Einar S. Björnsson et al.   GASTROENTEROLOGY

Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations

(2013) David E. Kleiner et al.   HEPATOLOGY

Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice

(2013) Martin S. Tallman et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Severe hepatitis associated with tocilizumab in a patient with rheumatoid arthritis

(2013) M. Alfreijat et al.   RHEUMATOLOGY

Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myeloma

(2012) Tom Cornelis et al.   CLINICAL TOXICOLOGY

Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma

(2012) David E. Kleiner et al.   DIGESTIVE DISEASES AND SCIENCES

Severe Pazopanib-Induced Hepatotoxicity: Clinical and Histologic Course in Two Patients

(2012) Samuel J. Klempner et al.   JOURNAL OF CLINICAL ONCOLOGY

Hépatite aiguë médicamenteuse à l’anakinra chez une patiente traitée pour une maladie de Still de l’adulte

(2012) A. Diallo et al.   REVUE DE MEDECINE INTERNE

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

(2011) Ayako Suzuki et al.   HEPATOLOGY

Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?

(2011) Maciej Bogdan Maniecki et al.   LEUKEMIA RESEARCH

Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop

(2010) Robert J. Fontana et al.   HEPATOLOGY

Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis

(2010) Einar Björnsson et al.   HEPATOLOGY

Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

(2010) Laura Rubbia-Brandt et al.   HISTOPATHOLOGY